Quinoxaline-6-carboxylic acid

Catalog No.: 
ACBKVM234
CAS No.: 
6925-00-4
Molecular Formula: 
C9H6N2O2
Molecular Weight: 
174.16
Quinoxaline-6-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$95.00In stockIn stock
100g97%$379.00In stockIn stock
500g97%$1528.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameQuinoxaline-6-carboxylic acid
IUPAC Namequinoxaline-6-carboxylic acid
MDL No.MFCD01365834
Molecular FormulaC9H6N2O2
Molecular Weight174.16
SMILESO=C(C1=CC=C2N=CC=NC2=C1)O
InChI KeyJGQDBVXRYDEWGM-UHFFFAOYSA-N
SynonymA836411 | JGQDBVXRYDEWGM-UHFFFAOYSA-N | SDCCGMLS-0065958.P001 | Quinoxaline-6-carboxylic acid | FT-0621314 | Z56957505 | EN300-17566 | CS-D1100 | 11X-0826 | AM804237 | VU0421326-2 | AB01324454-02 | AKOS000268250 | 6-Quinoxalinecarboxylic acid | SY004481 |
CAS No.6925-00-4
PubChem CID674813

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H319
Precautionary Statement(s)
P305+P351+P338

Synthetic Route by SureRoute

1. ACBKVM234 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBUTH952 route compound structure diagram
    ACBUTH95223088-23-5In Stock
  2. Then
  3. ACBKVM234 route product structure diagram
    ACBKVM2346925-00-4In Stock
Inquiry

2. ACBKVM234 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOXGD972 route compound structure diagram
    ACOXGD9726344-72-5In Stock
  2. Then
  3. ACBKVM234 route product structure diagram
    ACBKVM2346925-00-4In Stock
Inquiry

3. ACBKVM234 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAHXK291 route compound structure diagram
    ACAHXK291619-05-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBKVM234 route product structure diagram
    ACBKVM2346925-00-4In Stock
Inquiry

Comments (0)